发明人刘建华,徐明华,黄志刚. "一种恩格列净杂质141的合成方法" [P]. 中国发明专利, 专利号 CN 116315541 A, 授权公告日 2021-10-18.
Anderson J P, Brown S R, Klinger H. "Method for the Synthesis of Empagliflozin Impuirity 141" [P]. US Patent, US 11645943 B2, 2016-06-04.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 恩格列净杂质141 in Pharmaceutical Formulations". Talanta, 2010, 1114, (3), 6055-6076.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩格列净杂质141 as an Impurity". J. Chromatogr. A, 2022, 1120, (7), 6015-6026.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Empagliflozin Impuirity 141 Using HRMS and NMR". J. Agric. Food Chem., 2014, 2034, (2), 1272-1281.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 恩格列净杂质141 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2020, 661, (5), 5167-5192.